Investors in Health

Solutions for Startups, Scaleups, Small & Medium Enterprises (SMEs) and Investors.North Ventures is a platform that provides access to invest directly in highly qualified and sought-after Danish growth companies, along with a number of Denmark's top venture funds and business angels.

SPM is a Czech investment group that is looking for interesting opportunities, especially for long-term investments.Czech investment group focusing on long-term investments in companies with strong management and innovative ideas, with an initial investment size ranging from 10 to 200 million CZK per opportunity.

i&i Prague is a bio-innovation center partner for biotech innovations and smart money investments.i&i Prague is located in the heart of Europe, specializing in identifying and investing in new inventions in Drug Discovery, Diagnostics, MedTech, and other Life Science fields. They support projects from academic institutions.

Exoverse is an XR venture fund investing in innovative VR, AR, Metaverse and web3 companies to help build and support innovative ideas.Exoverse is a global XR venture fund specializing in investing in innovative VR, AR, Metaverse, and Web3 companies. We support groundbreaking ideas in the virtual and augmented reality space, offering opportunities for private investors and companies.

Nextech Ventures is a venture capital fund that invests in seed stage companies in the e-commerce, analytics, SaaS, and VR sectors.Nextech Ventures provides essential seed stage capital and a nimble team that makes fast decisions. They offer standard term sheets, international VC exposure, and a founders' network. With experience in e-commerce, retail, analytics, SaaS.

Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to develop tomorrow’s standard of care to cure cancer & infectious diseases and improve patient quality of life.

Family venture office investing in early-stage tech companies. We stand by our founders & provide long term deep support.Q Capital is a family venture office in Prague, Czech Republic, investing in early stage technological companies in the Central and Eastern European region. They partner with companies with software-based products, focusing on proven product market.

TCF Capital is an investment and family property management firm founded by entrepreneur Tomáš Čupr. The company's mission is to preserve, develop, and appreciate both investment portfolios and entrusted family assets.

Principal Investment Company focusing on early stage technology ventures.Polar Light Ventures focuses on seed stage investments in Europe in the Technology and Internet space

Yaya Capital is a healthcare investment firm that operates in a multi-stage strategy aimed at empowering top entrepreneurs by providing strategic support, specialized knowledge and connectivity through its robust network. Far beyond money, we put our experience, knowledge and execution capabilities to support companies that will improve the life and health of people around the world. With presence in Brazil, Switzerland, US (Palo Alto and New York) and Portugal, we are a global team of investors, entrepreneurs, scientists, doctors and innovation experts with proven experience in the healthcare industry.

emma Ventures invests into early-stage companies and supports their founders on their journey to change the world for the better. We invest in creative, open-minded and impact-driven founders with brilliant minds. We have a strong focus on diverse teams in terms of gender, race or backgrounds as we strongly believe in their overperformance. Equally important, we look for companies on a mission to create a positive impact on society and environment. Our focus areas are Digital Healthcare, Software/SAAS, Fintech, Insurtech, Edtech, Foodtech and Consumer.

We are SWEN BLUE OCEAN, SWEN Capital Partners’ direct impact strategy dedicated to investing in innovations that regenerate ocean health, thereby contributing to achieving SDG14. We back startups that deliver both systemic impact and competitive market returns. Our focus is on solutions addressing overfishing, ocean pollution, and mitigating climate change through marine solutions.